    {
        "title": "3.2 PMTCT",
        "type": "object",
        "properties": {
            "who_know_their_hiv_status_before_anc_1": {
                "line_number": "1",
                "fr": "Qui connaissent leur statut sérologique VIH avant l a CPN1",
                "en": "Who know their HIV status before ANC 1",
                "condition": "true"
            },
            "who_were_counseled_for_hiv_test": {
                "line_number": "2",
                "fr": "Qui ont été conseillée pour un test VIH",
                "en": "Who were counseled for HIV test",
                "condition": "true"
            },
            "who_were_hiv_tested": {
                "line_number": "3",
                "fr": "Qui ont été testées pour le VIH",
                "en": "Who were HIV tested",
                "condition": "true"
            },
            "who_were_informed_about_their_result": {
                "line_number": "4",
                "fr": "Qui ont été informées du résultat",
                "en": "who were informed about their result",
                "condition": "true"
            },
            "who_had_hiv_test": {
                "line_number": "5",
                "fr": "Qui ont eu un test positif au VIH",
                "en": "Who had HIV+ test",
                "condition": "true"
            },
            "who_had_hiv_test_and_were_informed_about_their_results": {
                "line_number": "6",
                "fr": "Qui ont eu un test positif au VIH et ont été informées du résultat",
                "en": "Who had HIV+ test and were informed about their results",
                "condition": "true"
            },
            "who_are_hiv_and_beneficiated_a_prophylaxie_at_arv_azt_3tc_nvp)": {
                "line_number": "7",
                "fr": "Qui sont VIH+ ayant bénéficié de la prophylaxie aux ARV (AZT /AZT+3TC+NVP)",
                "en": "Who are HIV+ and beneficiated a prophylaxie at ARV (AZT+3TC+NVP)",
                "condition": "true"
            },
            "who_are_hiv_and_beneficiated_a_prophylaxie_and_cotrimoxazole": {
                "line_number": "8",
                "fr": "Qui sont VIH+ ayant bénéficié de la prophylaxie au cotrimoxazole",
                "en": "Who are HIV+ and beneficiated a prophylaxie and cotrimoxazole",
                "condition": "true"
            },
            "who_are_hiv_and_refered_to_a_pec_center": {
                "line_number": "9",
                "fr": "Qui sont VIH+ qui sont référées vers une structure de PEC",
                "en": "Who are HIV+ and refered to a PEC center",
                "condition": "true"
            },
            "tested_and_informed_about_their_results_during_labour_delivery_and_post_portum_72": {
                "line_number": "10",
                "fr": "Testées et informées de leur résultat lors du trava il, accouchement et post partum (72 h)",
                "en": "Tested and informed about their results during labour, delivery and post-portum (72)",
                "condition": "true"
            },
            "pregnant_women_put_under_arvt": {
                "line_number": "11",
                "fr": "Femmes enceintes ont été mis sous TARV",
                "en": "Pregnant women put under ARVT",
                "condition": "true"
            },
            "who_were_pregnants_after_being_raped": {
                "line_number": "12",
                "fr": "Qui ont eu la grossesse à l’issue d’un Viol",
                "en": "Who were pregnants after being raped",
                "condition": "true"
            },
            "hiv_mother_who_opted_the_breast_feeding_up_to_6_months": {
                "line_number": "13",
                "fr": "Mères VIH+ ayant opté pour l’allaitement exclusif jusqu’à 6 mois",
                "en": "HIV+ mother who opted the breast feeding up to 6 months",
                "condition": "true"
            },
            "who_were_tested_for_ghonorrhea": {
                "line_number": "14",
                "fr": "?",
                "en": "Who were tested for Ghonorrhea",
                "condition": "true"
            },
            "hiv_mother_put_under_double_protection_pf_preservatif": {
                "line_number": "15",
                "fr": "Dont mères VIH+ mises sous double protection (PF+ préservatif)",
                "en": "HIV+ mother put under double protection (PF+ preservatif)",
                "condition": "true"
            },
            "delivered_hiv": {
                "line_number": "16",
                "fr": "?",
                "en": "Delivered HIV+",
                "condition": "true"
            },
            "including_those_have_received_the_nevirapine_azt_lav": {
                "line_number": "17",
                "fr": "Dont ayant reçu de la névirapine + AZT+LAV",
                "en": "Including those have received the Nevirapine + AZT + LAV",
                "condition": "true"
            },
            "children_born_from_hiv_mothers_who_were_put_under_nevirapine_at_birth": {
                "line_number": "18",
                "fr": "Enfants nés de mère VIH+",
                "en": "Children born from HIV+ mothers who were put under nevirapine at birth.",
                "condition": "true"
            },
            "who_were_put_under_cotrimoxazole_during_6_weeks_after_birth": {
                "line_number": "19",
                "fr": "Dont mis sous cotrimoxazole pendant 6 semaines après la naissance",
                "en": "Who were put under cotrimoxazole during 6 weeks after birth",
                "condition": "true"
            },
            "who_were_put_under_nevirapine_during_the_12_months_after_birth": {
                "line_number": "20",
                "fr": "Dont mis sous NVP pendant 12 mois après la naissance",
                "en": "Who were put under Nevirapine during the 12 months after birth",
                "condition": "true"
            },
            "exposed_children_who_were_tested_hiv_at_pcr_1_after_6_weeks_after_birth": {
                "line_number": "21",
                "fr": "Enfants exposés reçus et testés au PCR1 à 6 semaines après la naissance",
                "en": "Exposed children who were tested HIV+ at PCR 1 after 6 weeks after birth",
                "condition": "true"
            },
            "exposed_children_who_were_tested_at_pcr_2_at_10_weeks_after_birth": {
                "line_number": "22",
                "fr": "Enfants exposés reçus et testés au PCR2 à 10 semaines après la naissance",
                "en": "Exposed children who were tested at PCR 2 at 10 weeks after birth",
                "condition": "true"
            },
            "exposed_children_who_were_tested_hiv_at_pcr2_at_10_weeks_after_birth": {
                "line_number": "23",
                "fr": "Enfants exposés testés positifs au PCR2 à 10 semai nes après la naissance",
                "en": "Exposed children who were tested HIV+at PCR2 at 10 weeks after birth",
                "condition": "true"
            },
            "exposed_children_tested_at_pcr1_who_receiveda_hiv_test_at_12_months": {
                "line_number": "24",
                "fr": "Enfants exposés testés au PCR1 ayant bénéficié d'untest séro. à 12 mois",
                "en": "Exposed children tested at PCR1 who receiveda HIV test at 12 months",
                "condition": "true"
            }
        },
        "definitions": {
            "columns": {
                "number": {
                    "fr": "Nombre",
                    "en": "Number",
                    "title":"Number",
                    "condition": "true"
                }
            }
        }
    }
